遺伝子治療生産2.0に適したテクノロジー集約プロセス
遺伝子治療生産2.0に適したテクノロジー集約プロセス
Repligen is ready to partner with gene therapy developers and manufacturers, providing technology breakthroughs and high impact solutions for plasmid and viral vector manufacturing. May 12, 2020 | 11 minutes
12年5月
Discover More Webinars
01
02
03
04
05
01
/
05
ウェビナー
Automating the UF/DF Process with In-Line Concentration Measurement to Reduce Cycling Time and Accelerate PD
8年5月
ウェビナー
Innovative, differentiated technologies advancing new modalities: Case studies in mRNA & viral vectors
Feb 23
ウェビナー
ウェビナー
ウェビナー
Disruptive technologies transforming upstream process intensification for all modalities
Feb 2
11:00 EDT